(Q79706327)
Statements
Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial (English)
J Hinojosa
F Gomollón
S García
C Saro
D Ceballos
M Peñate
M A Gassull
Spanish Scientific Group on Crohn's Disease and Ulcerative Colitis
1 February 2007